Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CUE Key Statistics
Stock Snapshot
Cue Biopharma(CUE) stock is priced at $0.22, giving the company a market capitalization of 23.27M. It carries a P/E multiple of -0.76.
As of 2026-03-28, Cue Biopharma(CUE) stock has fluctuated between $0.17 and $0.24. The current price stands at $0.22, placing the stock +27.8% above today's low and -9.0% off the high.
Cue Biopharma(CUE) shares are trading with a volume of 1.14M, against a daily average of 3.98M.
In the last year, Cue Biopharma(CUE) shares hit a 52-week high of $1.05 and a 52-week low of $0.17.
In the last year, Cue Biopharma(CUE) shares hit a 52-week high of $1.05 and a 52-week low of $0.17.
CUE News
The latest announcement is out from Cue Biopharma ( (CUE) ). On March 26, 2026, Cue Biopharma’s board appointed Chief Financial and Business Officer Lucinda Wa...
Cue Biopharma (CUE) announced that Lucinda Warren, who has served as Cue Biopharma’s chief financial and business officer since February and previously as Cue B...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.